Murchinson Ltd. Biogen Inc. Transaction History

Murchinson Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4.87 Million - $6.71 Million	-25,000 Reduced 50.0%	25,000 $6.68 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $937,700 - $1.12 Million	5,000 Added 11.11%	50,000 $10.2 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $4.84 Million - $6.1 Million	25,000 Added 125.0%	45,000 $9.48 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.41 Million - $1.85 Million	5,000 Added 33.33%	20,000 $5.66 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $3.89 Million - $6.22 Million	15,000 New	15,000 $5.19 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

Stay updated on Murchinson Ltd. with notifications on news.